Digital health: are we doing this right?
As digital health ups its cred and penetrates healthcare, it encounters more serious evaluation. Case in point: wearables have matured from a hot tracking fad to “needing more specialization.” (ICYMI: We dove deep into this topic in our report.) And clinical validation? More and more founders understand its importance—but retain the spirit of technology by taking "advantage of the rapid, iterative, launch-and-fix-bugs pace of software." Keep up the good work—we're proud to be on this journey with all of you!
We're also proud to announce five of the largest healthcare providers backed Augmedix in a $17M round to rehumanize the doctor/patient relationship using Google Glass.
Headlines
Dear Silicon Valley: There Are No Shortcuts In Healthcare
Tweet | Fast Company
UnitedHealth To Exit Obamacare In 16 States To Stem Losses
Tweet | Bloomberg
Hearing Aids Under Pressure From Consumer Electronics
Tweet | The New York Times
Why Does Silicon Valley Want To Get So Many Women Pregnant?
Tweet | Motherboard
AstraZeneca To Scour 2M Genomes For Rare Disease Genes
Tweet | STAT
How Medicare Penalizes Hospitals For Being Too Careful
Tweet | The New York Times
FDA’s Foray Into Big Data Still Maturing
Tweet | JAMA
Headlines
Augmedix Nabs $17M To ‘Rehumanize’ Doctor/Patient Relations Using Google Glass
Tweet | TechCrunch
Omada Health Takes Aim At Diabetes With 'Digital Therapeutics'
Tweet | Fortune
Funding
| Company | Amt | Investors | Source |
| Brighter.com | $21M | General Catalyst Partners, DAG Ventures, Mayfield Fund, Benchmark Capital, Tenaya Capital | MedCity News |
| HealthVerity | $7.1M | Flare Capital Partners, Greycroft | MedCity News |
| ChartSpan | $3.2M | Undisclosed | MobiHealthNews |
| EverlyWell | $2.5M | Undisclosed | MobiHealthNews |
| NurseGrid | $2.5M | Excelerate Health Ventures, Toba Capital | Portland Business Journal |
Correction to last week's edition: Quartet raised $40M.
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.